Price tag fears cast shadow over ‘revolutionary’ leukemia drug – CNN – CNN
CNN |
Price tag fears cast shadow over ‘revolutionary’ leukemia drug – CNN
CNN When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like “breakthrough.” But when they think about how much the … The Promising New Cancer Treatment Behind Gilead’s $11 Billion …Fox Business |
Devon Live |
Devon scientist plans to develop Borg technology
Devon Live A Devon scientist inspired by Star Trek enemies The Borg plans to create living nanotechnology which will be integrated into ‘biological machines’. Dr Raymond Sparrow says synthetic biology could be the basis of a whole new industry and he has written … |
|
So Long To KITE; JUNO, CLLS, MBIO, BLCM Are Sympathy Plays; PGNX Catches Eye
Nasdaq Kite Pharma is a clinical-stage developer of chimeric antigen receptor (CAR) T-cell therapies. CAR T-cells are a type of immunotherapy in which a patient’s T cells are extracted from their blood and modified in a lab to produce receptors on their … |
Los Angeles Times |
FDA cracks down on clinics selling unproven stem cell ‘therapies’
Los Angeles Times The Food and Drug Administration has launched an opening salvo at a booming national market for suspect medical treatments, announcing actions that could rein in clinics offering questionable stem–cell treatments for cancer and other diseases. The FDA … FDA Cracks Down on ‘Unscrupulous’ Stem Cell ClinicsNew York Times FDA Cracks Down On Stem–Cell Clinics Selling Unapproved TreatmentsNPR FDA cracks down on stem cell clinicsCNN Ars Technica –Washington Post –Minneapolis Star Tribune –FDA.gov all 44 news articles » |
FierceBiotech |
Boosting immunotherapy by targeting cells’ recycling centers
FierceBiotech A subpopulation of cells in the immune system called CD8+ T cells are vital for the proper functioning of both vaccines and cancer immunotherapy treatments. When these cells divide, they become one of two types of pathogen-destroying soldiers: those … Boosting immune cell memory to improve vaccines and cancer immunotherapyEurekAlert (press release) |